Reducing ASCVD Risk in CKD

Kidney Commute
30/10/2024 46 min Episodio 26
Reducing ASCVD Risk in CKD

Listen "Reducing ASCVD Risk in CKD"

Descargar episodio Ver en sitio original

Episode Synopsis

People with kidney disease are at an increased risk for atherosclerotic cardiovascular disease, or ASCVD, and cardiovascular disease is the leading cause of death in people with kidney disease. In this episode of the Kidney Commute our interprofessional panel of experts discusses what ASCVD is, how patients can be evaluated for their ASCVD risk, and strategies for managing and reducing this risk. We cover risk calculators, pharmaceutical options, communication strategies, and areas where we can all work together to educate patients about risk. Thank you for joining us on this ride of The Kidney Commute!
 
Click here to claim CE Credit. 

More episodes of the podcast Kidney Commute

Pitstop: Uromodulin 13/12/2025
Pitstop: Part 2: Obesity in the Nephrology Clinic – Treatment and Management Principles 01/12/2025
Pitstop: Part 1: Obesity in the Nephrology Clinic – Risks, Roles, and Real-World Strategies 01/12/2025
Pitstop: Can a Nephrologist Say "No" to Dialysis? 13/10/2025
Pitstop: Applying eGFR Trends to Clinical Practice when Treating Patients with IgAN 02/10/2025
Benefits of Medical Nutrition Therapy (MNT) 22/09/2025
Pitstop: The Nephrologist’s Perspective in Evaluation and Management of Localized Renal Masses: Core Curriculum 2025 11/09/2025
Pitstop: Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025 27/08/2025
Vascular Access and Home Hemodialysis 12/08/2025
Pitstop: Continuous Kidney Replacement Therapies from the Core Curriculum 2025 29/07/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA